Microarray gene expression analysis revealed the strong upregulation of <i>INSM1</i>, a prominent <i>ASCL1</i> target, which was previously shown to be induced in CLL cells upon IL-4 treatment. This evidence concerns the gene INSM1 and B-cell chronic lymphocytic leukemia.